4.5 Article

Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs Results from a retrospective cohort study

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age

Arduino A. Mangoni et al.

CURRENT PHARMACEUTICAL DESIGN (2019)

Review Cell Biology

Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence

Arduino A. Mangoni et al.

MEDIATORS OF INFLAMMATION (2017)

Review Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

LANCET (2016)

Review Biochemistry & Molecular Biology

Smoking and Rheumatoid Arthritis

Kathleen Chang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Rheumatology

Remission in Early Rheumatoid Arthritis: Predicting Treatment Response

Margaret H. Y. Ma et al.

JOURNAL OF RHEUMATOLOGY (2012)

Article Rheumatology

Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis

G. S. Metsios et al.

ANNALS OF THE RHEUMATIC DISEASES (2008)

Article Medicine, General & Internal

Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women

Karen H. Costenbader et al.

AMERICAN JOURNAL OF MEDICINE (2006)